The drugmaker Ely Lilly ( LLY -4.93%) has had a very successful run over the long run. Shares currently trade around $818 and are up 20,030% over the past 40 years. The stock has also performed well ...
Eli Lilly became the second drugmaker this week to sue the U.S. government for rejecting their proposed changes to a program ...
Lilly also said Wednesday that sales for another diabetes treatment, Trulicity ... more than twice what the company registered for 2023. Shares of Indianapolis-based Eli Lilly and Co. were ...
The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain ...
Eli Lilly (LLY) has filed a lawsuit against the heads of the Department of Health and Human Services and one of its agencies, seeking a court ...
With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...
and Trulicity for type 2 diabetes; and Zepbound for obesity. Receive News & Ratings for Eli Lilly and Company Daily - Enter your email address below to receive a concise daily summary of the latest ...
That included several boxes containing counterfeit Ozempic, Wegovy and Trulicity ... only company in the U.S. with FDA-approved medicines containing the main ingredient semaglutide. FDA has not ...